Medicare Part D upped limitations on drugs, coverage … Several factors can predict urinary, fecal incontinence … Alternative pharmacies lack on generic drugs … Flu rising in central states as COVID,...
Clinical briefs for Friday, Jan. 19
By
Kristen Fischer
Jan 19, 2024
Large-scale study of those of African descent spots genetic variants tied to glaucoma … Brain stimulation kept quality of life stable after 5 years in people with Alzheimer’s … Insurers must apply...
Clinical briefs for Thursday, Dec. 15
By
Kristen Fischer
Dec 15, 2023
Biden team aims to lower drug costs with inflation penalties … Xarelto has higher risk for bleeding complications than others in class … Receptive music therapy improves cognitive function, depression...
Who benefits behind the scenes from high prescription drug prices?
By
Alan G. Rosenbloom
Oct 16, 2023
If there’s one thing most Americans still agree on, it’s that the ever-increasing cost of healthcare is simply unsustainable. And while there is plenty of blame to go around, one must look at who benefits...
Manufacturers of 10 selective drugs are all in for Medicare price negotiations
By
Kristen Fischer
Oct 04, 2023
Pharmaceutical companies that make the first 10 prescription drugs on Medicare’s prospective price negotiation list have agreed to participate in possible cost reductions.
Clinical briefs for Monday, June 28
By
Alicia Lasek
Jun 28, 2021
To save itself, Medicare could deny coverage of controversial new Alzheimer’s drug, expert predicts … Aduhelm most appropriate for early dementia, MCI, experts say … Eli Lilly to seek early approval...
Criticism, confusion and hope: new Alzheimer’s drug receives messy welcome
By
Alicia Lasek
Jun 15, 2021
Clinicians’ responses to the controversial approval of Aduhelm range between excitement and disapproval, with questions abounding on how to advise patients on treatment and the cost to patients and...
COVID-19 drug to cost Medicare $2,340 per course
By
Alicia Lasek
Jun 30, 2020
The antiviral remdesivir is priced “well below” the projected value of most patient treatments, the drugmaker says. Others claim the cost is too high, considering that its development was partly taxpayer...
Clinical Briefs for Friday, February 21
By
Alicia Lasek
Feb 20, 2020
Costs deter patients from taking their neurologic medications … Address patient complaints to lower risk of violence against nurses, say researchers … Hospital readmissions less likely when elders...
Clinical Briefs for Monday, October 21
By
Alicia Lasek
Oct 20, 2019
Verma: Drug ‘innovation doesn’t mean anything’ if it’s too costly … Research reveals why disordered eating is common in dementia … Harvard scientists pinpoint neural activity’s...